CAR-T immunotherapy provides customized treatment for a patient’s cancer. The therapy involves modifying a patient’s immune system T-cells to hunt and direct an attack against cancer cells. Through clinical trials, UNC Lineberger researchers are offering patients innovative treatments for cancers that have not responded to other treatments.

These stories offer insight about CAR-T therapy as an option for patients, and the possibilities it brings to cancer care.






Want to learn more about CAR-T clinical trials at UNC Lineberger?

Contact Us